glp 1 med GLP-1 Medications for Weight Loss: How to Get Started | News GLP-1 Medications Show Promise as

Virus protein ligands, like trimeric spike glycoprotein interact with cellular receptors, such as ACE2, and host proteases, like transmembrane protease serine 2 (TMPRSS2), participate in virus entry by proteolytically activating virus ligands (Sallenave and Guillot, 2020

Azoulay L, Filion KB, Platt RW, Dahl M, Dormuth CR, Clemens KK, et al

In a 48-week Phase 2 obesity trial, participants on the 12mg dose recorded a mean body-weight reduction of 24.2%, versus 2.1% on placebo[1]. 83% of that group lost 15% or more of their body weight, and 93% lost at least 10%[1]

Research suggests it may help protect cells from oxidative stress and support overall wellness

May 20 2020;19(1):48